Advanced search
1 file | 2.57 MB

Developing selective media for quantification of multispecies biofilms following antibiotic treatment

Eva Vandeplassche (UGent) , Tom Coenye (UGent) and Aurélie Crabbé (UGent)
(2017) PLOS ONE. 12(11).
Author
Organization
Abstract
The lungs of cystic fibrosis (CF) patients are chronically colonized by a polymicrobial biofilm community, leading to difficult-to-treat infections. To combat these infections, CF patients are commonly treated with a variety of antibiotics. Understanding the dynamics of polymicrobial community composition in response to antibiotic therapy is essential in the search for novel therapies. Culture-dependent quantification of individual bacteria from defined multi-species biofilms is frequently carried out by plating on selective media. However, the influence of the selective agents in these media on quantitative recovery before or after antibiotic treatment is often unknown. In the present study we developed selective media for six bacterial species that are frequently co-isolated from the CF lung, i.e. Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus anginosus, Achromobacter xylosoxidans, Rothia mucilaginosa, and Gemella haemolysans. We show that certain supplementations to selective media strongly influence quantitative recovery of (un) treated biofilms. Hence, the developed media were optimized for selectivity and quantitative recovery before or after treatment with antibiotics of four major classes, i.e. ceftazidime, ciprofloxacin, colistin, or tobramycin. Finally, in a proof of concept experiment the novel selective media were applied to determine the community composition of multispecies biofilms before and after treatment with tobramycin.
Keywords
CYSTIC-FIBROSIS PATIENTS, PSEUDOMONAS-AERUGINOSA, TRICLOSAN RESISTANCE, INFECTIONS, MICROBIOME, TOLERANCE, PATHOGENS, EFFLUX

Downloads

  • 8542887.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 2.57 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Vandeplassche, Eva, Tom Coenye, and Aurélie Crabbé. 2017. “Developing Selective Media for Quantification of Multispecies Biofilms Following Antibiotic Treatment.” Plos One 12 (11).
APA
Vandeplassche, E., Coenye, T., & Crabbé, A. (2017). Developing selective media for quantification of multispecies biofilms following antibiotic treatment. PLOS ONE, 12(11).
Vancouver
1.
Vandeplassche E, Coenye T, Crabbé A. Developing selective media for quantification of multispecies biofilms following antibiotic treatment. PLOS ONE. 2017;12(11).
MLA
Vandeplassche, Eva, Tom Coenye, and Aurélie Crabbé. “Developing Selective Media for Quantification of Multispecies Biofilms Following Antibiotic Treatment.” PLOS ONE 12.11 (2017): n. pag. Print.
@article{8543367,
  abstract     = {The lungs of cystic fibrosis (CF) patients are chronically colonized by a polymicrobial biofilm community, leading to difficult-to-treat infections. To combat these infections, CF patients are commonly treated with a variety of antibiotics. Understanding the dynamics of polymicrobial community composition in response to antibiotic therapy is essential in the search for novel therapies. Culture-dependent quantification of individual bacteria from defined multi-species biofilms is frequently carried out by plating on selective media. However, the influence of the selective agents in these media on quantitative recovery before or after antibiotic treatment is often unknown. In the present study we developed selective media for six bacterial species that are frequently co-isolated from the CF lung, i.e. Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus anginosus, Achromobacter xylosoxidans, Rothia mucilaginosa, and Gemella haemolysans. We show that certain supplementations to selective media strongly influence quantitative recovery of (un) treated biofilms. Hence, the developed media were optimized for selectivity and quantitative recovery before or after treatment with antibiotics of four major classes, i.e. ceftazidime, ciprofloxacin, colistin, or tobramycin. Finally, in a proof of concept experiment the novel selective media were applied to determine the community composition of multispecies biofilms before and after treatment with tobramycin.},
  articleno    = {e0187540},
  author       = {Vandeplassche, Eva and Coenye, Tom and Crabb{\'e}, Aur{\'e}lie},
  issn         = {1932-6203},
  journal      = {PLOS ONE},
  keyword      = {CYSTIC-FIBROSIS PATIENTS,PSEUDOMONAS-AERUGINOSA,TRICLOSAN RESISTANCE,INFECTIONS,MICROBIOME,TOLERANCE,PATHOGENS,EFFLUX},
  language     = {eng},
  number       = {11},
  pages        = {15},
  title        = {Developing selective media for quantification of multispecies biofilms following antibiotic treatment},
  url          = {http://dx.doi.org/10.1371/journal.pone.0187540},
  volume       = {12},
  year         = {2017},
}

Altmetric
View in Altmetric
Web of Science
Times cited: